共 78 条
[1]
Lassmann H(1998)Neuropathology in multiple sclerosis: new concepts Mult Scler 4 93-98
[2]
Bermel RA(2006)The measurement and clinical relevance of brain atrophy in multiple sclerosis Lancet Neurol 5 158-170
[3]
Bakshi R(2014)Clinical relevance of brain volume measures in multiple sclerosis CNS Drugs 28 147-156
[4]
De Stefano N(2015)Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis–establishing disease prognosis and monitoring patients Nat Rev Neurol 11 597-606
[5]
Airas L(2016)Whole-brain atrophy: ready for implementation into clinical decision-making in multiple sclerosis? Curr Opin Neurol 29 237-242
[6]
Grigoriadis N(2016)Automated brain volumetrics in multiple sclerosis: a step closer to clinical application J Neurol Neurosurg Psychiatry 87 754-757
[7]
Wattjes MP(2017)Effect of fingolimod on brain volume loss in patients with multiple sclerosis CNS Drugs 31 289-305
[8]
Rovira A(2002)Eight year follow-up study of brain atrophy in patients with MS Neurology 59 1412-1420
[9]
Miller D(2008)Gray matter atrophy is related to long-term disability in multiple sclerosis Ann Neurol 64 247-254
[10]
Azevedo CJ(2013)Brain atrophy and lesion load predict long term disability in multiple sclerosis J Neurol Neurosurg Psychiatry 84 1082-1091